PPA
RVLP

Parametric Portfolio Associates’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Parametric Portfolio Associates’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$32K Buy
+19,020
New +$27.2K ﹤0.01% 3648
2020
Q2 		– Sell
-10,091
Closed -$32K – 4029
2020
Q1 		$32K Buy
+10,091
New +$53.7K ﹤0.01% 3871

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MWM
Marietta Wealth Management Marietta, Georgia $971M AUM 25.37% 1-Year Est. Return
TC
Titleist Capital San Antonio, Texas $427M AUM 24.17% 1-Year Est. Return

Parametric Portfolio Associates's RVLP Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q1 2022: 19,020 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #3648 among its holdings. This is a return to the name: Parametric Portfolio Associates previously reported a position in RVLP as recently as Q1 2020.

Parametric Portfolio Associates first reported a position in RVLP in Q1 2020 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold RVLP as of Q1 2022.

  • Parametric Portfolio Associates held 19,020 shares of RVL Pharmaceuticals plc Ordinary Shares worth $32K as of Q1 2022.
  • RVL Pharmaceuticals plc Ordinary Shares was a new Parametric Portfolio Associates position in Q1 2022.
  • RVL Pharmaceuticals plc Ordinary Shares made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3648 holding.
  • Parametric Portfolio Associates first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2020 and has held it in 2 quarters since.
  • 36 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.